Leading Experts in Genomic Medicine and Cancer Research are Inaugural Members
Seven Bridges, the biomedical data analysis company, today announced its Scientific Advisory Board, which formalizes relationships with leading global experts in genomic medicine, bioinformatics and cancer research. Members of the Seven Bridges Scientific Advisory Board will advise on the company's product designs and strategies for cloud-based biomedical data analysis, as well as share their knowledge about key challenges and opportunities in the field of genomic research.
The inaugural members of the Seven Bridges Scientific Advisory Board include:
"As we continue to build on Seven Bridges' vision to connect the world's biomedical data for better research and health, input from leaders in the fields of genetics, bioinformatics and cancer research will prove invaluable to our efforts," said Brandi Davis-Dusenbery, CEO of Seven Bridges. "We are honored that these respected experts have agreed to participate in our SAB and look forward to working with them to constantly advance the state of the art in data analysis for our large-scale pharmaceutical and government clients."
About Seven Bridges
Seven Bridges is the biomedical data analysis company accelerating breakthroughs in genomics research for cancer, drug development and precision medicine. The scalable, cloud-based Seven Bridges Platform empowers rapid, collaborative analysis of millions of genomes in concert with other forms of biomedical data. Thousands of researchers in government, biotech, pharmaceutical and academic labs use Seven Bridges, including three of the largest genomics projects in the world: U.S. National Cancer Institute's Cancer Genomics Cloud pilot, the Million Veteran Program, and Genomics England's 100,000 Genomes Project. As the NIH's only commercial Trusted Partner, Seven Bridges authenticates and authorizes access to one of the world's largest cancer genomics dataset. Named one of the world's smartest companies by MIT Technology Review, Seven Bridges has offices in Cambridge, Mass.; Belgrade; London; Istanbul; and San Francisco.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170315005606/en/
Press: Seven Bridges Amanda Orr, +1-202-459-1304 or Laurie Gibson, +1-650-815-1438 media@sevenbridges.com